{"nct_id":"NCT03822117","title":"Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)","status":"TERMINATED","status_verified_date":"2023-03","start_date":"2019-10-17","start_date_type":"ACTUAL","primary_completion_date":"2022-03-29","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}